[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

MCRT Webcast: Experts Discuss COVID-19 and Myeloma - April 18, 2020

MCRT Webcast: Experts Discuss COVID-19 and Myeloma - April 18, 2020 image

MCRT Webcast: Experts Discuss COVID-19 and Myeloma - April 18, 2020

Roundtable
event Apr 18, 2020 / 09:00AM - 03:00PM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

The first ever Myeloma Crowd Round Table Webinar meeting was held on April 18, 2020, featuring three myeloma experts:

  • Matthew Fero, MD, University of New Mexico Comprehensive Cancer Center
  • Morie Gertz, MD, MACP, Mayo Clinic
  • Sundar Jagannath, MBBS, Mount Sinai Hospital

 

Thanks to our Round Table sponsors

  

 

 

Virtual Round Table, April 18, 2020

Experts Discuss COVID-19 and Myeloma

expand_more

Schedule & Agenda

Event panelist Dr. Matthew Fero, Dr. Morie Gertz, Dr. Sundar Jagannath
09:00 AM
Round Table
Dr. Matthew Fero, Dr. Morie Gertz, Dr. Sundar Jagannath

Speakers & Moderators

The panelist Dr. Matthew Fero
Dr. Matthew Fero

Dr. Fero's research interest is focused on the development of novel therapeutic agents for the treatment of hematological malignancies. Towards this aim, he is serving in three different leadership positions: 1) Director of the UNM Bone Marrow Transplant and Cell Therapy Program, which has brought autologous hematopoietic stem cell transplant technology to New Mexico, with the intent of introducing allogeneic stem cell transplant and both CAR-T therapy in the near future. Their program is currently undergoing FACT accreditation to further this aim. 2) He is the leader of the Hematology Clinical Working Group, a committee which reviews and prioritizes all clinical trials for hematological malignancies at UNM and affiliate NCORP community sites. 3) His laboratory uses preclinical models to identify novel therapeutic targets for hematological malignancies, and to test the therapeutic efficacy of novel agents. They have expertise in both the development of novel targeted and transgenic mice, as well as human tumor xenograft models to elucidate the oncogenic interactions of genes and carcinogenic compounds, in order to understand their potential risks and pathogenic mechanisms.

Read Bio
The panelist Morie Gertz, MD, MACP
Morie Gertz, MD, MACP

Morie Gertz, MD, MACP, is the Roland Seidler, Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, MN. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Gertz has also served as Treasurer of the International Myeloma Society and President of Mayo Staff Officers and Councilors. He was the Chair of the Mayo Personnel Committee. Currently he serves on the American Society of Hematology Training Program Committee and the American Board of Internal Medicine Hematology Board Exam Committee. Dr. Gertz has been recognized with the 2014 Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström Macroglobulinemia and is a Mayo Distinguished Clinician. He has been recognized for his contributions in amyloidosis and Waldenström macroglobulinemia, has authored more than five hundred peer-reviewed publications, and is a master of the America College of Physicians. He graduated from Northwestern University with highest distinction as a Phi Beta Kappa and received his medical degree cum laude from Loyola Medical School and was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush Presbyterian St. Luke’s Hospital in Chicago and was twice voted Resident of the Year.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.